Table 1.
Characteristic | |
---|---|
Total number of patients | 35 |
Age, yr (mean ± SD) | 69 ± 10 |
Men, n (%) | 26 (74) |
Women, n (%) | 9 (26) |
Surgical procedure | |
Coronary artery bypass surgery with or without AVR/MVR | 22 (63) |
AVR/MVR | 13 (37) |
Medical history | |
Smoker/exsmoker | 17 (49) |
Hypertension | 24 (69) |
Diabetes mellitus | 5 (14) |
Heart failure | 3 (9) |
Previous myocardial infarction | 9 (25) |
Chronic obstructive pulmonary disease/asthma | 3 (9) |
Smoker/exsmoker | 99 (56) |
Medications | |
Anticoagulants | 4 (11) |
Antiplatelets | 23 (66) |
β-Blockers | 23 (66) |
Statins | 25 (71) |
Ca2+ channel blockers | 8 (23) |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blocker | 21 (60) |
Diuretics | 14 (40) |
Values are total numbers of patients with percentages in parentheses unless indicated otherwise. AVR, aortic valve replacement; MVR, mitral valve replacement.